DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Shriram Finance Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·19 Oct 2026, 5:04 am

Shriram Finance

Shriram Finance has announced its schedule for an upcoming meeting with analysts and institutional investors. This event is a standard corporate procedure where the company management typically shares its business outlook, financial performance, and strategic plans with the market.

For investors, this disclosure is significant as it provides a window into the company's future direction. It allows the market to gauge management sentiment and gather insights that are not always visible in routine financial filings. It is a key event for those tracking the NBFC sector.

Investors should watch for the management's commentary on credit growth, asset quality, and capital adequacy ratios during the meeting. Following the event, the company will likely release a transcript or presentation slides, which will be crucial for validating the market's expectations.